Unknown

Dataset Information

0

Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.


ABSTRACT:

Background and objectives

Current hemodialysis techniques fail to efficiently remove the protein-bound uremic toxins p-cresyl sulfate and indoxyl sulfate due to their high degree of albumin binding. Ibuprofen, which shares the same primary albumin binding site with p-cresyl sulfate and indoxyl sulfate, can be infused during hemodialysis to displace these toxins, thereby augmenting their removal.

Design, setting, participants, & measurements

We infused 800 mg ibuprofen into the arterial bloodline between minutes 21 and 40 of a conventional 4-hour high-flux hemodialysis treatment. We measured arterial, venous, and dialysate outlet concentrations of indoxyl sulfate, p-cresyl sulfate, tryptophan, ibuprofen, urea, and creatinine before, during, and after the ibuprofen infusion. We report clearances of p-cresyl sulfate and indoxyl sulfate before and during ibuprofen infusion and dialysate concentrations of protein-bound uremic toxins normalized to each patient's average preinfusion concentrations.

Results

We studied 18 patients on maintenance hemodialysis: age 36±11 years old, ten women, and mean vintage of 37±37 months. Compared with during the preinfusion period, the median (interquartile range) clearances of indoxyl sulfate and p-cresyl sulfate increased during ibuprofen infusion from 6.0 (6.5) to 20.2 (27.1) ml/min and from 4.4 (6.7) to 14.9 (27.1) ml/min (each P<0.001), respectively. Relative median (interquartile range) protein-bound uremic toxin dialysate outlet levels increased from preinfusion 1.0 (reference) to 2.4 (1.2) for indoxyl sulfate and to 2.4 (1.0) for p-cresyl sulfate (each P<0.001). Although median serum post- and predialyzer levels in the preinfusion period were similar, infusion led to a marked drop in serum postdialyzer levels for both indoxyl sulfate and p-cresyl sulfate (-1.0 and -0.3 mg/dl, respectively; each P<0.001). The removal of the nonprotein-bound solutes creatinine and urea was not increased by the ibuprofen infusion.

Conclusions

Infusion of ibuprofen into the arterial bloodline during hemodialysis significantly increases the dialytic removal of indoxyl sulfate and p-cresyl sulfate and thereby, leads to greater reduction in their serum levels.

SUBMITTER: Madero M 

PROVIDER: S-EPMC6419294 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.

Madero Magdalena M   Cano Karla B KB   Campos Israel I   Tao Xia X   Maheshwari Vaibhav V   Brown Jillian J   Cornejo Beatriz B   Handelman Garry G   Thijssen Stephan S   Kotanko Peter P  

Clinical journal of the American Society of Nephrology : CJASN 20190212 3


<h4>Background and objectives</h4>Current hemodialysis techniques fail to efficiently remove the protein-bound uremic toxins p-cresyl sulfate and indoxyl sulfate due to their high degree of albumin binding. Ibuprofen, which shares the same primary albumin binding site with p-cresyl sulfate and indoxyl sulfate, can be infused during hemodialysis to displace these toxins, thereby augmenting their removal.<h4>Design, setting, participants, & measurements</h4>We infused 800 mg ibuprofen into the art  ...[more]

Similar Datasets

| S-EPMC6938492 | biostudies-literature
| S-EPMC10818225 | biostudies-literature
| S-EPMC4626712 | biostudies-literature
| S-EPMC5583320 | biostudies-literature
| S-EPMC6669440 | biostudies-literature
| S-EPMC5652810 | biostudies-literature
| S-EPMC4404563 | biostudies-literature
| S-EPMC9436783 | biostudies-literature
| S-EPMC10059720 | biostudies-literature
| S-EPMC4310659 | biostudies-literature